Amundi’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.69M | Sell |
202,800
-253,989
| -56% | -$4.62M | ﹤0.01% | 977 |
|
|
2025
Q1 | $26.8M | Buy |
456,789
+3,057
| +0.7% | +$179K | 0.01% | 660 |
|
|
2024
Q4 | $57.3M | Buy |
453,732
+95,813
| +27% | +$12.1M | 0.02% | 533 |
|
|
2024
Q3 | $42.9M | Buy |
357,919
+24,963
| +7% | +$2.99M | 0.02% | 574 |
|
|
2024
Q2 | $51M | Sell |
332,956
-65,330
| -16% | -$10M | 0.02% | 519 |
|
|
2024
Q1 | $46.4M | Sell |
398,286
-1,081
| -0.3% | -$126K | 0.02% | 537 |
|
|
2023
Q4 | $47.8M | Buy |
399,367
+91,880
| +30% | +$11M | 0.02% | 538 |
|
|
2023
Q3 | $36.3M | Buy |
307,487
+2,036
| +0.7% | +$240K | 0.02% | 575 |
|
|
2023
Q2 | $34.7M | Buy |
305,451
+92,319
| +43% | +$10.5M | 0.02% | 594 |
|
|
2023
Q1 | $29.3M | Buy |
213,132
+187,369
| +727% | +$25.8M | 0.02% | 632 |
|
|
2022
Q4 | $3.09M | Buy |
25,763
+23,359
| +972% | +$2.81M | ﹤0.01% | 1111 |
|
|
2022
Q3 | $266K | Hold |
2,404
| – | – | ﹤0.01% | 1420 |
|
|
2022
Q2 | $198K | Hold |
2,404
| – | – | ﹤0.01% | 1360 |
|
|
2022
Q1 | $213K | Hold |
2,404
| – | – | ﹤0.01% | 1378 |
|
|
2021
Q4 | $174K | Hold |
2,404
| – | – | ﹤0.01% | 1493 |
|
|
2021
Q3 | $222K | Sell |
2,404
-14,671
| -86% | -$1.35M | ﹤0.01% | 1414 |
|
|
2021
Q2 | $1.33M | Buy |
+17,075
| New | +$1.33M | ﹤0.01% | 1196 |
|